Notice: Undefined index: eventTitle in /var/www/vhosts/bio2bevents.com/httpdocs/events-home.php on line 315

With an academic background in physical chemistry, Gareth has worked at the business/science interface of Almac for 3 years. He applies his expertise to assist the pharma and biotech communities in the UK, Ireland, Germany and Israel to streamline their drug development plans by engaging the vast array of integrated services available at Almac. Gareth has particular interest in the provision of peptides.

James Willson joined Shire Pharmaceuticals in September 2011 as a Senior Clinical Scientist

He holds a PhD in Neuropharmacology obtained at the University of Southampton in 2003.  After a brief postdoctural position again at Southampton University he left to begin a career in clinical research.

In 2004 James joined the Clinical Research Organisation ICON Clinical Research as a Clinical Research Associate.  In 2010, he became a project manager at ICON. While at ICON he worked on a number of global trials (with sites in EU, Americas, Asia Pacific) in various indications.

Currently at Shire Pharmaceuticals he is a study manager working on a large global programme of clinical trials.

Gareth is currently a Functional Sourcing Manager based at Pfizer UK, located in Walton Oaks, near Dorking in Surrey. Gareth has been involved in Clinical Research for over 20 years, working across a broad range of drug development programmes covering phases I-IV. Most of Gareth’s experience has been gained within the commercial arena of pharmaceutical companies, designing and implementing trials which have supported the development of some of the most well-known & commercially successful prescription medicines. As Director of the UK Clinical Research Group at Pfizer, Gareth has led that organisation through several significant organisational changes, including the integration with Wyeth. In his current role, Gareth has supported the implementation of an outsourced clinical operations partnership with Quintiles, involving the delivery of clinical trials across 30 countries globally.  Over the past 2 years, Gareth has led the complex transition of ongoing clinical trials between CRO partners, in order to achieve strategic organisational goals.

Tamzin has worked for Lilly for 20 years in a variety of roles, starting in the analytical labs, progressing to be a project manager and most recently as part of the outsourcing group. In this role she is responsible for placing all phase I work outside of the US. In addition she is the relationship manager for the phase I strategic relationship with Covance. She has a degree and PhD in Chemistry.

Pia Sauer Larsen, R&D Outsourcing Manager, Clinical Outsourcing Management, LEO Pharma A/S

Pia Sauer Larsen – with 15 years’ experience in various roles related to Clinical Development, Pia is currently working in the R&D Outsourcing Function at LEO Pharma A/S, a leading global pharma company specialising in dermatology and critical care.

Previously Pia was working as Strategic Procurement management function at Genmab A/S, and in a DM role at Nycomed Denmark Aps mainly focusing on the relationship and outsourced DM services between DM CROs and the clinical teams and also spent more than 8 years in a Data Management Unit at a centralized imaging CRO and in the Danish Cancer Society. 

Steve Greentree is currently the Director Global Portfolio Management for
biologics at Mylan GmbH in Zurich Switzerland. His responsibilities include
portfolio, program and project management for the range of biosimilar
products in Mylan's development pipeline. As a relative newcomer to the
field of biosimilars he is particularly interested in the development and
application of standard portfolio and program management methods to support
this business model. In this position he applies the knowledge and
expertise gained from more than 25 years spent in a variety of drug
development positions in the pharmaceutical and biotechnology industry.